🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
1.290
-0.130 (-9.15%)
At close: Nov 20, 2026, 4:00 PM EST
1.310
+0.020 (1.55%)
After-hours: Nov 20, 2026, 7:41 PM EST

Quantum BioPharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-20.14-26.18-14.2-17.9-23.61-35.29
Depreciation & Amortization
0.510.550.492.514.534.05
Other Amortization
1.491.49----
Loss (Gain) From Sale of Assets
0.120.12----
Asset Writedown & Restructuring Costs
---4.56--
Loss (Gain) From Sale of Investments
0.01-0.4300.380.230.86
Stock-Based Compensation
2.342.950.153.841.537.44
Other Operating Activities
7.2811.29-3.08-5.84-2.760.68
Change in Accounts Receivable
-0.450.2-0.150.160.22-0.11
Change in Inventory
0.080.07-0.12---
Change in Accounts Payable
1.271.184.272.05-0.73.6
Change in Unearned Revenue
--11---
Change in Other Net Operating Assets
0.921.544.75-0.57-6.64-0.61
Operating Cash Flow
-6.56-8.24-6.88-10.83-28.33-20.75
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-----0.11-
Cash Acquisitions
---0.03-0.77
Sale (Purchase) of Intangibles
-----0.25-0.5
Investment in Securities
0.421.18-0.5-0.74-0.24-
Other Investing Activities
-4.07-3.13-10.4412.73-
Investing Cash Flow
-3.65-1.95-1.5-0.2712.120.27

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-2.110.31---
Long-Term Debt Issued
-3.240.7---
Total Debt Issued
2.745.361.01---
Short-Term Debt Repaid
--1.5----0.07
Long-Term Debt Repaid
--0.11-0.06-0.19-0.14-0.06
Lease Payments
-0.11-0.11-0.06-0.19-0.14-0.06
Total Debt Repaid
-1.82-1.61-0.06-0.19-0.14-0.13
Net Debt Issued (Repaid)
0.923.750.95-0.19-0.14-0.13
Issuance of Common Stock
10.690.5310.670.02-38.34
Repurchase of Common Stock
----2.96-1.93-
Other Financing Activities
1.721.82----
Financing Cash Flow
13.326.111.62-3.13-2.0738.21

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
3.11-4.093.24-14.22-18.2817.73

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-6.56-8.24-6.88-10.83-28.45-20.75
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.14-2.51-6.05-17.78-47.74-38.59
Levered Free Cash Flow
-2.33-6.83-5.13-15.51-2.75-8.19
Unlevered Free Cash Flow
-2.6-7-5.1-15.51-2.72-8.15
Free Cash Flow After Leases
-6.67-8.35-6.94-11.02-28.59-20.8

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
1.821.999.761.64-7.122.89
SEC Filings: 10-K · 10-Q